5-(4-Chlorobutyl)-1-cyclohexyl tetrazole, 95.0%, 25g

O,O'-(Propane-1,3-diyl)bis(hydroxylamine) dihydrochloride, 98%, 100mg

Recipiente de cristalización ROTILABO® con pico, 150 ml, 80 mm, 10 Unidad(es)

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino)phenyl)acetamide, 97%, 1g

2,2,3',4'-tetramethylpropiophenone, 97.0%, 1g

(R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride, 95.0%, 100mg

4'-Nitrobenzo-15-crown 5-Ether>99.0%(GC)1g

Ethyl 4-methylpent-4-enoate, 97.0%, 5g

4-(Benzyloxy)-1-bromo-2-(trifluoromethyl)benzene, 95%, 250mg

N-Me-Thr(Tbu)-OH, 95.0%, 1g

trans-Zeatin>98.0%(HPLC)(N)100mg

4-Bromo-2-chloroiodobenzene, 97.0%, 100g

Ethyl 3-Bromoimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 5g